Cooper St et al. demonstrated the utility of MyoD gene-modified fibroblasts for research and diagnosis of human muscle disorders, reproducing protein deficiencies associated with different forms of muscular dystrophy and providing a renewable source of muscle-specific mRNA [31]. This evidence concerns the gene MYOD1 and muscular dystrophy.